Both vaccines are mRNA based, made by Moderna and Pfizer. Here’s how they compare with each other. Judge rules Trump unlawfully invoked Alien Enemies Act against alleged Tren de Aragua members ...

Pfizer has an Earnings ESP of -7.23% and a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Per our proven model, companies with the ...

Pfizer PFE will report its first-quarter earnings on April 29, before market open. The Zacks Consensus Estimate for sales and earnings for the first quarter is pegged at $13.88 billion and 67 ...

If you’re on the fence about investing in Amicus Therapeutics, Inc., Moderna or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

“I think it wins at summary judgment because it’s not complicated. If, for example, Pfizer or CVS is the only one federally licensed to sell a Schedule III product in a state, and your state is ...

The updated recommendation does not benefit Moderna Inc’s MRNA mRNA-based RSV vaccine mRESVIA (mRNA-1345), which is currently approved for adults over 60 years. William Blair notes Moderna ...

What's interesting about Pfizer stock is that the company has been punished for its own success. In 2020, it generated $41.9 billion in full-year sales, with no revenue from COVID-19 treatments.

Just because Wall Street has proved to be a superior wealth creator over the long run doesn't mean stocks are impervious to bouts of volatility. Since President Donald Trump announced his ...

A panel of advisers to the Centers for Disease Control and Prevention on Wednesday recommended lowering the age at which some people can receive a vaccine for respiratory syncytial virus, but stopped ...

and the other is weighing it as a booster for healthy adults who have previously received an approved Pfizer or Moderna mRNA vaccine. So far, the data suggest that the vaccine provides a more ...

Pediatric experts are calling for renewed focus on measles vaccination as outbreaks reappear in the U.S. Despite having been declared non-endemic, measles poses serious risks, especially to young ...